How tiny metal beads could make chemotherapy more effective for brain tumours

August 31, 2018 by Justine Alford, Cancer Research UK
Credit: CC0 Public Domain

Treatments for brain tumours aren't good enough. Only around 1 in 7 people will survive their disease for a decade or longer. And those in this small but fortunate fraction may also be left with lifelong reminders of their cancer in the form of side effects from their treatment.

But coming up with better ways to tackle these diseases is fraught with difficulty. This stems from the fact that tumours are hard to study in the lab. And their complex biology has held back the progress seen with treatments for other cancers.

For example, aggressive brain tumours, such as glioblastoma, quickly spread throughout the brain. This means surgery often won't be enough to treat the disease, because the operation can't remove all the . It's then only a matter of time before these invasive seed the tumour's return, and from there the person's outlook sadly becomes exceedingly bleak.

So, what's needed to turn this harrowing situation around? Our scientists are on the case. And they've come up with an innovative idea that they believe could be a game changer for these patients.

A masked attacker

One way that doctors try to deal with the rogue tumour cells left behind after surgery is , often with the drug temozolomide. But aren't specific to cancer cells – they target any cell that's growing quickly in the body. They can therefore cause serious side effects that limit how much of the drug can be given, and that limits their effectiveness.

Researchers at the Cancer Research UK Edinburgh Centre have come up with an idea to solve this issue – and we gave them one of our Pioneer Awards to get it off the ground.

Blending their complementary scientific skills, neurosurgeon Dr. Paul Brennan and chemist Professor Asier Unciti-Broceta are developing a new way to make chemotherapy more targeted, and therefore hopefully more effective.

Credit: Cancer Research UK

Their two-pronged approach involves modifying the chemotherapy drug temozolomide and creating a harmless implant to be inserted into the brain. The modified drug and implant eventually work together at the tumour site to essentially become a mini drug-making factory.

They're tweaking the drug so that it's inactive when given to the patient. They essentially give it a 'mask', which means it can travel around the body without causing any unwanted harm to growing that it meets.

That's until the drug reaches the implant: tiny beads made from the metal palladium. These would be placed inside the brain around the area where the tumour was removed during surgery. When the encounters the metal, it gets switched on in the perfect place to potentially kill any that might be left in the brain.

To find out more, we visited the team in Edinburgh. Watch the video below to see what they've been up to.

Beyond brains

By creating a localised attack, the scientists hope that side effects from the chemotherapy will be greatly reduced. That means more chemotherapy could be given, and hopefully that could mean a longer life for the patient.

It's early days and this approach is still being developed in the lab, so it could be some time before reaching patients. But the results from cancer cells in Petri dishes so far have been encouraging, and the scientists now have their sights set further than . Radioactive implants are sometimes used for prostate , for example, so they've already started research in mice to explore its potential for this disease too.

While there's still much to be done, hopefully one day this bright idea will become something meaningful for patients.

Explore further: Scientists exploit leaks in blood brain barrier to treat glioblastoma

Related Stories

Scientists exploit leaks in blood brain barrier to treat glioblastoma

November 6, 2017
An ovarian cancer drug can leak through the blood brain barrier to reach brain tumours and could be an effective treatment for glioblastoma, suggest results presented at the National Cancer Research Institute's (NCRI) Cancer ...

Brain tumour chemotherapy now available to even more NHS patients

July 11, 2018
Science can be a painstakingly slow process. It can take years of tweaking, refining and rethinking to get solid, reliable evidence. And when it comes to developing new cancer treatments, the layers of research needed go ...

CAR-T therapy works for some blood cancers, but can we make it work for brain tumours?

July 26, 2018
A powerful new anti-cancer therapy, called CAR-T, has shown great promise in treating blood cancers. Last year, the Food and Drug Administration approved the treatment for acute lymphoblastic leukaemia, and the results have ...

New method reveals how well cancer drugs hit their targets

July 12, 2018
Scientists have developed a technique that allows them to measure how well cancer drugs reach their targets inside the body. It shows individual cancer cells in a tumour in real time, revealing which cells interact with the ...

Teamwork between cells fuels aggressive childhood brain tumor

July 2, 2018
Scientists have discovered that cancerous cells in an aggressive type of childhood brain tumour work together to infiltrate the brain, and this finding could ultimately lead to much needed new treatments, according to a new ...

Antifungal drug eliminates sleeping bowel cancer cells in mice

May 31, 2018
An antifungal medication, commonly prescribed for toenail infections, could help eliminate dormant cells within bowel tumours, according to new research funded by Cancer Research UK and published in the Journal of Experimental ...

Recommended for you

Could the zika virus fight the brain cancer that killed john McCain?

September 18, 2018
(HealthDay)—Preliminary research in mice suggests that the Zika virus might be turned from foe into friend—enlisted to curb deadly glioblastoma brain tumors.

Eating foods with low nutritional quality ratings linked to cancer risk in large European cohort

September 18, 2018
The consumption of foods with higher scores on the British Food Standards Agency nutrient profiling system (FSAm-NPS), reflecting a lower nutritional quality, is associated with an increased risk of developing cancer, according ...

CRISPR screen reveals new targets in more than half of all squamous cell carcinomas

September 18, 2018
A little p63 goes a long way in embryonic development—and flaws in p63 can result in birth defects like cleft palette, fused fingers or even missing limbs. But once this early work is done, p63 goes silent, sitting quietly ...

Enlarged genotype-phenotype correlation for a three-base pair deletion in neurofibromatosis type 1

September 18, 2018
International collaborative research led by Ludwine Messiaen, Ph.D., shows that while a three-base pair, in-frame deletion called p.Met992del in the NF1 gene has a mild phenotype for people with the genetic disorder neurofibromatosis ...

Artificial intelligence can determine lung cancer type

September 17, 2018
A new computer program can analyze images of patients' lung tumors, specify cancer types, and even identify altered genes driving abnormal cell growth, a new study shows.

Researchers develop mechanism for characterizing function of rare tumor cells

September 17, 2018
Scientists have long known that circulating tumor cells, rare cancer cells that are released into the bloodstream, have the potential to provide vital information about a person's specific cancer. But until now, they have ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.